Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction. - Wikidata - awgldk - TriplyDB

Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction.

Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction.

http://www.wikidata.org/entity/Q33746096

about

Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now?Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart Disease Advanced cell therapies: targeting, tracking and actuation of cells with magnetic particles Magnetic field-guided cell delivery with nanoparticle-loaded human corneal endothelial cells.Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.Magnetic resonance hypointensive signal primarily originates from extracellular iron particles in the long-term tracking of mesenchymal stem cells transplanted in the infarcted myocardium.Magnetically Targeted Stem Cell Delivery for Regenerative Medicine.Human mesenchymal stem cells labelled with dye-loaded amorphous silica nanoparticles: long-term biosafety, stemness preservation and traceability in the beating heart.Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles.Inhibition of Viability, Proliferation, Cytokines Secretion, Surface Antigen Expression, and Adipogenic and Osteogenic Differentiation of Adipose-Derived Stem Cells by Seven-Day Exposure to 0.5 T Static Magnetic Fields.The diagnostic value of iron oxide nanoparticles for imaging of myocardial inflammation--quo vadis?The potential for nanotechnology to improve delivery of therapy to the acute ischemic heart.Magnetic targeting as a strategy to enhance therapeutic effects of mesenchymal stromal cells.Magnet-Bead Based MicroRNA Delivery System to Modify CD133+ Stem Cells.Externally Applied Static Magnetic Field Enhances Cardiac Retention and Functional Benefit of Magnetically Iron-Labeled Adipose-Derived Stem Cells in Infarcted Hearts.Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles.Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine.Iron-induced myocardial injury: an alarming side effect of superparamagnetic iron oxide nanoparticles Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells.Retrograde Coronary Venous Infusion as a Delivery Strategy in Regenerative Cardiac Therapy: an Overview of Preclinical and Clinical Data.

P2860

Q26739877-9E315835-8AFC-4D12-BD96-FE9B2294CB6C Q26770129-15CA89B0-FC4E-4889-825A-D86591BD5D18 Q26782710-30D564C6-6C92-4CE6-8AA3-A05D05429999 Q27308612-9DFB1886-7FD7-4BE5-AA25-4ED6BB4A20CB Q33746524-44768325-7364-40FD-9346-7C303B085082 Q35162387-CE076416-739E-40B0-A47D-CEF2D5A7B2DF Q36138808-8C6793D6-CF42-497E-801E-CE5DA230B57E Q36224187-61C31E1D-DE41-407D-B617-76649C289B4B Q36408240-2DC83224-F73E-4E17-9241-B21F42D79C5A Q36530820-5494BAA0-D2DE-45AE-9E3E-DB5C59BEDD3D Q38543648-DC4AF5F8-EF6D-4237-84DC-2417CBE81340 Q38775962-6FB79047-8ABD-4846-AE4A-081D42FC38D5 Q39171316-724B1A15-575C-42E1-A02E-485303669B15 Q41482927-6EE31630-9730-48C1-A4D4-5BD15AD5D71E Q41657655-F20AFCF2-E3A7-4DA6-97FA-8F0138B96817 Q42044067-435F5860-454A-4897-8C18-6E86B34BFCE5 Q42359748-458F5DC5-B33D-44FA-AA9C-12F0342AE683 Q42838830-C0450E7D-6073-4857-9B80-5FCC4AD7498B Q45867825-E5DA2BBA-14CE-4170-B2E2-04B2454D8224 Q47697828-6EC6CE73-FF47-4F12-A04D-37EF9E622190

P2860

Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction.

http://www.wikidata.org/entity/Q33746096

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Magnetic targeting enhances re ...... odel of myocardial infarction.

@ast

Magnetic targeting enhances re ...... odel of myocardial infarction.

@en

type

label

Magnetic targeting enhances re ...... odel of myocardial infarction.

@ast

Magnetic targeting enhances re ...... odel of myocardial infarction.

@en

prefLabel

Magnetic targeting enhances re ...... odel of myocardial infarction.

@ast

Magnetic targeting enhances re ...... odel of myocardial infarction.

@en

P1433

Q33746096-E70A82C0-93C8-436D-A11A-963A9E25A0CD

P1476

Q33746096-2962DD1E-A4E8-4699-BDA9-DA59F70C06A6

P2093

Q33746096-040C94E3-B991-4DAB-A2F0-AAF1C15B998A

Q33746096-2D0A9EE9-6686-4627-9D45-A8F798350274

Q33746096-3E3E09CC-B772-4227-B8F0-3C6A6E06D0A4

Q33746096-4EE9A597-B108-4616-B46E-338E826DC438

Q33746096-51B7563C-4824-4096-8912-FEE7F989FE45

Q33746096-674D8148-4E8C-46E0-A09D-CE975CB33332

Q33746096-86C8B45C-4039-4B07-9208-D777E59F1E84

Q33746096-8C54A3F5-8A86-4F96-9A49-75AEB934A849

Q33746096-8DF9567A-8762-40C2-848E-42849911C3D8

Q33746096-9CC051C3-846F-4FA6-961D-EF4C7C500B67

P2860

Q33746096-04607967-3ED2-4E14-8BCB-0AFAAEDE7350

Q33746096-05BC8BD3-B8D7-40AD-8221-77CED61004A8

Q33746096-199B9E78-FD0E-4832-AE97-BE91A5D089AE

Q33746096-1E706A97-101D-45AB-989A-5A6A2FCD682B

Q33746096-24F3F697-0B9B-461D-93B3-63061E20CFD3

Q33746096-268465A9-7FA1-4D63-9D6E-7CE594E3B729

Q33746096-2A473103-92C6-4D14-BBC6-8C161E299AA5

Q33746096-3B2CCA54-A7F5-43B7-BC9B-8E7533B1E674

Q33746096-3BE3E258-04CB-4717-A7BC-8A8D6367FADD

Q33746096-3EB13131-3A24-456C-9199-8CFBFA5EA298

P2888

Q33746096-CC0FCF7E-A311-4704-8B98-BC414346BDBB

P304

Q33746096-9ADB8D65-8F47-40EB-A969-61825AF07A1E

P31

Q33746096-6FE6BFB1-BF20-4BA1-929E-FF2C2564126D

P356

Q33746096-15F34A7C-DE99-4AF2-A296-9BA39CA15132

P433

Q33746096-EABD88B0-8C6E-4222-8E3A-16106B85DEF5

P478

Q33746096-62B87770-A2E2-476C-81BC-ED8653F238F5

P577

Q33746096-35ED1315-6142-4CA8-84D4-BD07035D9069

P5875

Q33746096-40C4AD78-596B-44AA-9C98-BD117C4D8181

P6179

Q33746096-A516944D-D195-41DE-B4EE-4672A3A3143E

P698

Q33746096-AB5B3E8B-1F93-4A70-A15E-1A191F00D0C1

P932

Q33746096-9951FD82-FE98-4D89-B179-1A3CBC91E484

P356

P1433

Stem Cell Research & Therapy

P1476

Magnetic targeting enhances re ...... odel of myocardial infarction.

@en

P2093

Aijun Sun

http://www.w3.org/2001/XMLSchema#string

Bingqing Huang

http://www.w3.org/2001/XMLSchema#string

Gangyong Huang

http://www.w3.org/2001/XMLSchema#string

Hongmin Zhu

http://www.w3.org/2001/XMLSchema#string

Jianfeng Xu

http://www.w3.org/2001/XMLSchema#string

Jing Ma

http://www.w3.org/2001/XMLSchema#string

Junbo Ge

http://www.w3.org/2001/XMLSchema#string

Juying Qian

http://www.w3.org/2001/XMLSchema#string

Ning Pei

http://www.w3.org/2001/XMLSchema#string

Xiangdong Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics

A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease.

Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat.

Functional investigations on human mesenchymal stem cells exposed to magnetic fields and labeled with clinically approved iron nanoparticles

Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery.

Assessment and optimization of cell engraftment after transplantation into the heart.

Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction.

New coronary retroinfusion technique in the Rat infarct model: transjugular cardiac vein catheterization.

The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling.

Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion

P2888

P304

149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/SCRT360

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259316138

http://www.w3.org/2001/XMLSchema#string

P6179

1038133318

http://www.w3.org/2001/XMLSchema#string

P698

24330751

http://www.w3.org/2001/XMLSchema#string

P932

4055006

http://www.w3.org/2001/XMLSchema#string